retatrutide trial results just delivered the first top-line Phase 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Triumph-1 Trial Results for Retatrutide

Remember that upper arm injections often require assistance from another person

Sergey Terushkin , MD, FACS, is a board-certified surgeon with extensive experience in bariatric surgery and physician-guided medical weight loss

173 SalvatoreTPafundiPCGalieroRRinaldiLCaturanoAVetranoEet al

GLP-1 RAs have been shown to result in increased RGCs in patients undergoing EGDs and poor BBPSs in those undergoing colonoscopies

Zepbound (tirzepatide) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, type 2 diabetes, or dyslipidemia

Do Not Depend Only on Appetite Signals After stopping GLP-1 Medications for Weight Loss, hunger cues may feel different from what patients experienced during treatment